
|Articles|February 11, 2008
FDA's crackdown on bio-identical hormones sparks controversy
Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement







































